MedTrace Logo

BONAMI (BOne Marrow in Acute Myocardial Infarction)

NCT00200707 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2014-04-30

No results posted yet for this study

Summary

Emerging evidence suggests that stem cells and progenitor cells derived from bone marrow can be used to improve cardiac function in patients after acute myocardial infarction. In this randomised trial, we aim to assess whether intracoronary transfer of autologous bone-marrow cells could improve myocardial viability at 3 and 12 months' follow-up.

Conditions

  • Acute and Severe Myocardial Infarction

Interventions

PROCEDURE

Intracoronary injection of autologous bone marrow mononuclear cells

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Patricia LEMARCHAND, MD · Nantes University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2009-01-31
Completion
2009-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200707 on ClinicalTrials.gov